Options traders still see huge risk after Valeant CEO ouster
NEW YORK, March 21 (Reuters) - Options traders in U.S.-listed shares of Valeant Pharmaceuticals International Inc are bracing for more volatility, as changes to the drugmaker's management and board...
No comments:
Post a Comment